Panagora Asset Management’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-600
Closed -$21K 2555
2019
Q2
$21K Sell
600
-83
-12% -$3.69K ﹤0.01% 2269
2019
Q1
$37K Sell
683
-98
-13% -$6.44K ﹤0.01% 2116
2018
Q4
$42K Sell
781
-15
-2% -$1.04K ﹤0.01% 2005
2018
Q3
$70K Sell
796
-78
-9% -$6.39K ﹤0.01% 1947
2018
Q2
$85K Sell
874
-530
-38% -$37.4K ﹤0.01% 1893
2018
Q1
$123K Sell
1,404
-2,599
-65% -$180K ﹤0.01% 1805
2017
Q4
$211K Buy
4,003
+2,891
+260% +$145K ﹤0.01% 1655
2017
Q3
$60K Sell
1,112
-240
-18% -$14.6K ﹤0.01% 2020
2017
Q2
$94K Buy
1,352
+874
+183% +$61.7K ﹤0.01% 1895
2017
Q1
$36K Hold
478
﹤0.01% 2068
2016
Q4
$20K Hold
478
﹤0.01% 2223
2016
Q3
$33K Buy
+478
New +$38.5K ﹤0.01% 2193
2014
Q4
Sell
-9
Closed -$7K 2318
2014
Q3
$7K Sell
9
-4
-31% -$3.5K ﹤0.01% 2245
2014
Q2
$13K Buy
+13
New +$12.6K ﹤0.01% 2271

Other funds holding LSTA

Panagora Asset Management's LSTA Position: Q3 2019 in Review

Panagora Asset Management sold out of Lisata Therapeutics (LSTA) in Q3 2019, closing a stake of 600 shares — an estimated $21K sold.

Panagora Asset Management first reported a position in LSTA in Q2 2014 and held it in 14 quarters. The position peaked at $211K in Q4 2017. 25 funds tracked by Wall St. Rank hold LSTA as of Q3 2019.

  • Panagora Asset Management reported no remaining Lisata Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 600 Lisata Therapeutics shares in Q3 2019, an estimated $21K.
  • Panagora Asset Management first reported a position in Lisata Therapeutics in Q2 2014 and held it in 14 quarters.
  • Panagora Asset Management's Lisata Therapeutics position peaked at $211K in Q4 2017.
  • 25 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.